Menu
Not yet recruiting NCT07180485

Effectiveness of Whole Body Vibration on Health Outcomes in Older Adults With Dynapenic Abdominal Obesity

No phase Interventional Dynapenia Abdominal Obesity

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: whole body vibration training, control group.
Who it may be relevant to
Registry conditions: Dynapenia, Abdominal Obesity. Basic parameters: 65 years — 100 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Center list to be confirmed — check the primary protocol.
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

The Effectiveness of Whole Body Vibration Training in Improving Brain Activity, Bone Mineral Density, Quality of Life, and Biomarkers for the Older People With Dynapenic Abdominal Obesity

Overview

This study focuses on whole body vibration training (WBVT), a form of neuromuscular training that uses mechanical vibrations. WBVT has been shown to improve muscle function, bone mineral density, and quality of life. While some benefits have been observed in the elderly population, there remains a research gap concerning its effectiveness in older adults with dynapenic abdominal obesity. Therefore, the findings of this study will provide new evidence for health interventions targeting this specific group. This research targets outpatients aged 65 and above who meet the criteria for dynapenic abdominal obesity. It aims to evaluate the effects of WBVT on brain activity, osteoporosis, quality of life, and biological markers. The study period is from February 1, 2025, to January 31, 2027, with a planned sample size of 120 participants, equally divided into an experimental group and a control group (60 participants each).

Detailed description

The purpose of this study is to investigate the effects of whole body vibration training on older adults with dynapenic abdominal obesity in the following areas:

Brain activity: Changes in serum levels of brain-derived neurotrophic factor (BDNF).

Bone mineral density: Measured using dual-energy X-ray absorptiometry (DXA).

Quality of life: Assessed through questionnaires covering improvements in physical health, mental well-being, and social functioning.

Biomarkers: Changes in levels of total cholesterol, high- and low-density lipoprotein cholesterol, C-reactive protein (CRP), and glycated hemoglobin (HbA1c).

Interventions

  • Behavioral whole body vibration training
    whole body vibration training and health education booklet
  • Behavioral control group
    health education booklet

Primary outcome measures

  • blood tests [Time frame: 24 weeks]
  • dual-energy X-ray absorptiometry(DXA) [Time frame: 8 months]
  • quality of life questionnaire [Time frame: 24 weeks]

Eligibility criteria

Inclusion criteria

Outpatients aged 65 years or older

Diagnosed with dynapenic abdominal obesity

Able to understand and follow simple instructions

Able to communicate clearly and express their own will

Willing to sign the informed consent form

Exclusion criteria

Inability to communicate in Mandarin or Taiwanese, resulting in inability to participate in research activities

Severe visual or hearing impairment that hinders study participation

Presence of cognitive impairment, musculoskeletal or severe osteoporosis-related conditions

Refusal to sign the informed consent form

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Prevention

Study locations

Center list to be confirmed — check the primary protocol.

Publications

  • Zago M, Capodaglio P, Ferrario C, Tarabini M, Galli M. Whole-body vibration training in obese subjects: A systematic review. PLoS One. 2018 Sep 5;13(9):e0202866. doi: 10.1371/journal.pone.0202866. eCollection 2018. PMID 30183742
  • Zhang L, Liu S, Wang W, Sun M, Tian H, Wei L, Wu Y. Dynapenic abdominal obesity and the effect on long-term gait speed and falls in older adults. Clin Nutr. 2022 Jan;41(1):91-96. doi: 10.1016/j.clnu.2021.11.011. Epub 2021 Nov 15. PMID 34864458
  • Zhang J, Wang R, Zheng Y, Xu J, Wu Y, Wang X. Effect of Whole-Body Vibration Training on Muscle Activation for Individuals with Knee Osteoarthritis. Biomed Res Int. 2021 Mar 26;2021:6671390. doi: 10.1155/2021/6671390. eCollection 2021. PMID 33855078
  • Yao G, Chung CW, Yu CF, Wang JD. Development and verification of validity and reliability of the WHOQOL-BREF Taiwan version. J Formos Med Assoc. 2002 May;101(5):342-51. PMID 12101852
  • Wang X, Jiang J, Hu W, Hu Y, Qin LQ, Hao Y, Dong JY. Dynapenic Abdominal Obesity and Risk of Heart Disease among Middle-Aged and Older Adults: A Prospective Cohort Study. J Nutr Health Aging. 2023;27(9):752-758. doi: 10.1007/s12603-023-1975-0. PMID 37754215
  • Wolf D, Ayon-Olivas M, Sendtner M. BDNF-Regulated Modulation of Striatal Circuits and Implications for Parkinson's Disease and Dystonia. Biomedicines. 2024 Aug 5;12(8):1761. doi: 10.3390/biomedicines12081761. PMID 39200225
  • Wang W, Wang S, Lin W, Li X, Andersen LL, Wang Y. Efficacy of whole body vibration therapy on pain and functional ability in people with non-specific low back pain: a systematic review. BMC Complement Med Ther. 2020 May 27;20(1):158. doi: 10.1186/s12906-020-02948-x. PMID 32460819
  • Wu S, Ning HT, Xiao SM, Hu MY, Wu XY, Deng HW, Feng H. Effects of vibration therapy on muscle mass, muscle strength and physical function in older adults with sarcopenia: a systematic review and meta-analysis. Eur Rev Aging Phys Act. 2020 Sep 17;17:14. doi: 10.1186/s11556-020-00247-5. eCollection 2020. PMID 32963629

Identifiers

NCT: NCT07180485 · B11401015 · DTCRD113-E-14

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗